Rang	Name	Position
1	Dr. Bobak R. Azamian M.D.	Co-Founder, President, CEO & Chairman
2	Dr. Seshadri Neervannan Ph.D.	Chief Operating Officer
3	Dr. Bryan Wahl J.D., M.D.	General Counsel & Corporate Secretary
4	Mr. David Nakasone	Head of Investor Relations
5	Ms. Adrienne Kemp	Vice President of Corporate Communications
6	Mr. Matthew Rossen M.B.A.	Vice President of Marketing
7	Mr. Scott Youmans	Vice President of Sales
8	Ms. Dianne C. Whitfield M.S.W.	Chief Human Resources Officer
9	Dr. Elizabeth Yeu-Lin M.D.	Chief Medical Officer
10	Ms. Cara Miller	Senior Vice President of Corporate Affairs

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	8,24%	0,28 Mrd. USD
2	Deep Track Capital, LP	7,84%	0,26 Mrd. USD
3	RTW INVESTMENTS, LLC	7,17%	0,24 Mrd. USD
4	Jupiter Topco LLC	6,00%	0,20 Mrd. USD
5	Paradigm Biocapital Advisors LP	5,93%	0,20 Mrd. USD
6	HHG PLC	4,79%	0,16 Mrd. USD
7	Assenagon Asset Management SA	4,05%	0,14 Mrd. USD
8	Morgan Stanley - Brokerage Accounts	3,90%	0,13 Mrd. USD
9	Vanguard Capital Management, LLC	3,83%	0,13 Mrd. USD
10	Jennison Associates LLC	3,56%	0,12 Mrd. USD
11	TANG CAPITAL MANAGEMENT LLC	3,35%	0,11 Mrd. USD
12	Millennium Management LLC	3,05%	0,10 Mrd. USD
13	Bank of America Corp	2,55%	0,09 Mrd. USD
14	Geode Capital Management, LLC	2,36%	0,08 Mrd. USD
15	State Street Corp	2,29%	0,08 Mrd. USD
16	Vestal Point Capital LP	2,24%	0,08 Mrd. USD
17	Amvescap Plc.	1,68%	0,06 Mrd. USD
18	The Goldman Sachs Group Inc	1,59%	0,05 Mrd. USD
19	Frazier Life Sciences Management, L.P.	1,56%	0,05 Mrd. USD
20	D. E. Shaw & Co LP	1,52%	0,05 Mrd. USD